Disease/Infection News

RSS

Research could provide more effective treatment against West Nile virus

Protecting ourselves from backyard mosquito bites may come down to leaving the vacuuming for later, a study from York University shows.

29 Jun 2010

Foreign Policy examines GHI, PEPFAR

Foreign Policy examines reactions to the priorities set forth in President Barack Obama's Global Health Initiative (GHI) and what they might mean for PEPFAR.

29 Jun 2010

Efforts to contain drug-resistant malaria near Thai-Cambodian border appear to be working, officials say

A two-year effort aimed at preventing the emergence of drug-resistant malaria near the border between Cambodia and Thailand is showing signs of success, Duong Socheat, head of Cambodia's National Center for Malaria Control, said on Friday, DPA/Earth Times reports.

29 Jun 2010

Ahead of International AIDS Conference, health experts call for scientifically-based drug policies

Ahead of the International AIDS Conference, scheduled to kick off July 18, health experts on Monday called for a rethinking of international drug policies to incorporate greater scientific evidence and increase access to HIV prevention, treatment and care, the Associated Press reports (6/28).

29 Jun 2010

'Beeglue' may help deliver new treatments for fatal infections

Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug, according to research led at the University of Strathclyde in Glasgow, Scotland.

29 Jun 2010

IAVI announces Japanese pledge of $10M for AIDS vaccine research and development

The International AIDS Vaccine Initiative (IAVI) announced today that the Government of Japan pledged a US$10 million grant to support AIDS vaccine research and development over the next five years. The grant, which will be channeled through a newly established World Bank trust fund, is the first of its kind from the Japanese government to IAVI.

28 Jun 2010

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

28 Jun 2010

Wake Forest Professor awarded $2.8M NHLBI grant to study ways to make transfusions using older blood safer

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, announced June 21st that it will fund nine research grants to improve the safety of red blood cell transfusions.

28 Jun 2010

CDC fails to implement official HIV testing guidelines, AHF criticizes

As health departments, community organizations and AIDS advocates around the country observe National HIV Testing Day today, AIDS Healthcare Foundation criticized the Centers for Disease Control's for its failure to implement its own landmark 2006 change it its official HIV testing guidelines that included the recommendation for routine testing of all individuals ages 13-64 for HIV as they visit or encounter routine healthcare settings.

28 Jun 2010

AHF rejects Obama trial balloon of $30M for nation's ADAP

AIDS Healthcare Foundation, the largest global AIDS organization, is rejecting a trial balloon floated by Obama Administration officials that suggests $30 million in additional funding could adequately help close a gaping $126 million hole in funding for the nation's AIDS Drug Assistance Program, the federal and state funded, state run network of assistance programs that supply lifesaving AIDS drugs to low-income Americans in need.

28 Jun 2010

UNDP, UNAIDS launch Global Commission on HIV, Law

The U.N. Development Program together with UNAIDS on Thursday announced the formation of a commission to examine how legal environments affect HIV/AIDS efforts, VOA News reports (DeCapua, 6/24).

28 Jun 2010

Combination MMRV vaccine associated with increased risk of febrile seizures

The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox, according to a Kaiser Permanente Division of Research study appearing online in the journal Pediatrics. A febrile seizure is a brief, fever-related convulsion but it does not lead to epilepsy or seizure disorders, researchers explained.

28 Jun 2010

New affiliation formed to accelerate nation's progress in fighting HIV/AIDS

Two leading institutions in public health and health policy are joining forces to accelerate the nation's progress in fighting HIV/AIDS, hepatitis C and tuberculosis in Washington – the Forum for Collaborative HIV Research and the University of California, Berkeley, School of Public Health.

28 Jun 2010

Antioxidant therapy may prevent long-lasting cognitive impairment in cerebral malaria: Research

Using an experimental mouse model for malaria, an international group of scientists has discovered that adding antioxidant therapy to traditional antimalarial treatment may prevent long-lasting cognitive impairment in cerebral malaria. Their findings were published online June 24, 2010, in the journal PLoS Pathogens.

28 Jun 2010

Data on MetAP2 inhibitors for treatment of obesity presented at ADA 2010

Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced data on ZGN-201, a prototype methionine aminopeptidase 2 inhibitor, for the treatment of obesity. Preclinical studies demonstrate MetAP2 inhibition eliminates excess body weight through the regulation of fat metabolism and food intake, and normalizes glucose tolerance in animal models.

28 Jun 2010

FDA approves OraSure Technologies' OraQuick HCV Rapid Antibody Test

OraSure Technologies, Inc. announced today that its OraQuick Hepatitis C Rapid Antibody Test has been approved by the U.S. Food and Drug Administration for use in detecting HCV antibodies in venous whole blood specimens, making it the first rapid HCV test approved by the FDA for use in the United States.

28 Jun 2010

Mechanism that regulates stem-cell differentiation in mice may trigger degenerative disease in humans: Research

A mechanism that regulates stem-cell differentiation in mice testes suggests a similar process that may trigger degenerative disease in humans, according to a Penn State College of Agricultural Sciences reproductive physiologist.

28 Jun 2010

Florida seeks new tools to stop dengue outbreak

While all eyes are on the Gulf oil spill, another natural disaster worsens as Key West Florida battles the first U.S. outbreak of dengue in 75 years. With over 30 confirmed cases (27 in 2009, 8 in 2010) and 5% of residents showing exposure to the mosquito-spread disease, Florida is seeking new tools to stop the emerging threat. Aiming to enhance their existing control program, the Florida Keys Mosquito Control District turned to SpringStar Inc in Woodinville, WA.

28 Jun 2010

FDA approves OraQuick HCV Rapid Antibody Test for HCV

The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus for individuals 15 years and older.

25 Jun 2010

Sixth annual Mayors Campaign Against HIV launched to encourage people test for HIV

OraSure Technologies, Inc. and the National Association of People with AIDS announced today the launch of the sixth annual Mayors Campaign Against HIV, a national campaign to encourage testing for HIV and promote the benefits of knowing one's HIV status. The Campaign is part of the annual observance of National HIV Testing Day on Sunday, June 27, 2010.

25 Jun 2010

Disease/Infection News

Research could provide more effective treatment against West Nile virus

Foreign Policy examines GHI, PEPFAR

Efforts to contain drug-resistant malaria near Thai-Cambodian border appear to be working, officials say

Ahead of International AIDS Conference, health experts call for scientifically-based drug policies

'Beeglue' may help deliver new treatments for fatal infections

IAVI announces Japanese pledge of $10M for AIDS vaccine research and development

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Wake Forest Professor awarded $2.8M NHLBI grant to study ways to make transfusions using older blood safer

CDC fails to implement official HIV testing guidelines, AHF criticizes

AHF rejects Obama trial balloon of $30M for nation's ADAP

UNDP, UNAIDS launch Global Commission on HIV, Law

Combination MMRV vaccine associated with increased risk of febrile seizures

New affiliation formed to accelerate nation's progress in fighting HIV/AIDS

Antioxidant therapy may prevent long-lasting cognitive impairment in cerebral malaria: Research

Data on MetAP2 inhibitors for treatment of obesity presented at ADA 2010

FDA approves OraSure Technologies' OraQuick HCV Rapid Antibody Test

Mechanism that regulates stem-cell differentiation in mice may trigger degenerative disease in humans: Research

Florida seeks new tools to stop dengue outbreak

FDA approves OraQuick HCV Rapid Antibody Test for HCV

Sixth annual Mayors Campaign Against HIV launched to encourage people test for HIV

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News